packageCopanlisib

copanlisib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Copanlisib is a PI3K inhibitor investigated as a cancer treatment, notably for marginal zone lymphoma. Its marketing application in the European Union was withdrawn, so it is not authorised there.

Summary written by glm-5.3-flash from Wikidata Q19903876 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:copanlisib
ATC codes:L01EM02
DrugBank:DB12483
PubChem CID:24989044
ChEBI:173077
Wikidata:Q19903876
formula:C23H28N8O4
molar mass:480.529 g/mol (knowledgebase (DrugBank calculated))
logP:0.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown